VACI — what changed in the latest 10-Q

Text added vs the prior filing · source: 10-Q · 2026-05-15

• For the three months ended March 31, 2026, we had a net income of $1,734,928, which consisted of interest earned on cash and marketable securities held in Trust Account of $2,008,654 offset by $273,726 of general and administrative costs.

• On November 3, 2025, we consummated the Initial Public Offering of 23,000,000 Units, which includes the full exercise by the underwriters of their over-allotment option of 3,000,000 Units, at $10.00 per Unit, generating gross proceeds of $230,000,000. Simultaneously with the closing of the Initial P…

• For the three months ended March 31, 2026, net cash used in operating activities was $275,591. Net income of $1,734,928 was affected by interest earned on cash and marketable securities of $2,008,654 and changes in operating assets and liabilities, which used $1,865 of cash from operating activities…

• At March 31, 2026, we had cash and marketable securities held in the Trust Account of $233,476,543 (including approximately $3,476,543 of interest income). We intend to use substantially all of the funds held in the Trust Account, including any amounts representing interest earned on the Trust Accou…

• At March 31, 2026, we had cash of $997,656 held outside of the Trust Account. We intend to use the funds held outside the Trust Account primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants or sim…

Text removed vs the prior filing · source: 10-Q · 2025-12-15

• For the period from July 24, 2025 (inception) through September 30, 2025, we had a net loss $1,071,594, which consisted of general and administrative costs of $47,597 and share-based compensation expense of $1,023,997.

• Until the consummation of the Initial Public Offering, our only source of liquidity was an initial purchase of shares of Class B ordinary shares, par value $0.0001 per share, by the Sponsor and loans from the Sponsor.

• Subsequent to the quarterly period covered by this Quarterly Report on Form 10-Q, on November 3, 2025, we consummated the Initial Public Offering of 23,000,000 Units, which includes the full exercise by the underwriters of their over-allotment option of 3,000,000 Units, at $10.00 per Unit, generatin…

• For the period from July 24, 2025 (inception) through September 30, 2025, net cash used in operating activities was $0. Net loss of $1,071,594 was affected by payment of formation costs through promissory note – related party of $4,697, payment of general and administrative costs through promissory …

• We intend to use substantially all of the funds held in the Trust Account, including any amounts representing interest earned on the Trust Account (less income taxes payable), to complete our Business Combination. To the extent that our share capital or debt is used, in whole or in part, as consider…

Text added vs the prior filing · source: 10-Q · 2026-05-15

• As required by Rules 13a-15 and 15d-15 under the Exchange Act, our Chief Executive Officer and Chief Financial Officer carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as of March 31, 2026. Based upon their evaluation, our Chief Exe…

Text removed vs the prior filing · source: 10-Q · 2025-12-15

• Under the supervision and with the participation of our Management, including our Certifying Officers, we carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act. Based on …